Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcome

1 Jan 2000

Abstract excerpt

In a group of 26 524 control pregnancies and a group of 3728 pregnancies affected by one or more of the pregnancy complications of low birthweight, intra-uterine growth restriction (IUGR), preterm delivery and stillbirth, I have compared the relative risk of occurrence of these complications in pregnancies which had a raised maternal serum AFP (>2.0 MoM), raised maternal serum free beta-hCG (>2.0 MoM), low AFP...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Parvovirus B19 Infection Studies
Share to Pregnancy and preeclampsia studies
Share to Prenatal Screening and Diagnostics

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 10951476
DOI: 10.1002/1097-0223(200008)20:8<652::aid-pd882>3.0.co;2-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Second-trimester prenatal screening for Down syndrome and the relationship of maternal serum biochemical markers to pregnancy complications with adverse outcomePMID 10951476Read ↗

Screening of Maternal Serum for Fetal Down's Syndrome in the First TrimesterSemantic proximity Read ↗

Does a “vanishing twin” affect first-trimester biochemistry in Down syndrome risk assessment?Semantic proximity Read ↗

Prenatal Screening for Down's Syndrome with Use of Maternal Serum MarkersSemantic proximity Read ↗

Appropriate biochemical parameters in first-trimester screening for Down syndromeSemantic proximity Read ↗

Second‐trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnanciesSemantic proximity Read ↗

First‐trimester biochemical screening for fetal chromosome abnormalities and neural tube defectsSemantic proximity Read ↗

COMBINING INHIBIN A WITH EXISTING SECOND-TRIMESTER MARKERS IN MATERNAL SERUM SCREENING FOR DOWN'S SYNDROMESemantic proximity Read ↗

Additive effect of factors related to assisted conception on the reduction of maternal serum pregnancy-associated plasma protein A concentrations and the increased false-positive rates in first-trimester Down syndrome screeningSemantic proximity Read ↗

Down's syndrome screening in multiple pregnancies using alpha‐fetoprotein and free beta hCGSemantic proximity Read ↗

First‐trimester free beta (hCG) screening for Down syndromeSemantic proximity Read ↗

Second trimester serum tests for Down's Syndrome screeningSemantic proximity Read ↗

DOWN'S SYNDROME SCREENING MARKER LEVELS FOLLOWING ASSISTED REPRODUCTIONSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.